Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3298473017 | Parenteral form irinotecan (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 3298598018 | Parenteral form irinotecan | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3488586011 | Product containing irinotecan in parenteral dosage form (medicinal product form) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3497654013 | Irinotecan in parenteral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3497655014 | Product containing irinotecan in parenteral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3710467016 | Product containing irinotecan in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3710468014 | Irinotecan-containing product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Irinotecan-containing product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Irinotecan-containing product in parenteral dose form | Is a | Irinotecan-containing product | true | Inferred relationship | Some | ||
| Irinotecan-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Some | ||
| Irinotecan-containing product in parenteral dose form | Has active ingredient | Irinotecan | true | Inferred relationship | Some | 1 | |
| Irinotecan-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some | ||
| Irinotecan-containing product in parenteral dose form | Is a | Amino acid-containing product in parenteral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Irinotecan only product in parenteral dose form | Is a | True | Irinotecan-containing product in parenteral dose form | Inferred relationship | Some | |
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial | Is a | False | Irinotecan-containing product in parenteral dose form | Inferred relationship | Some | |
| Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial | Is a | False | Irinotecan-containing product in parenteral dose form | Inferred relationship | Some | |
| Irinotecan hydrochloride trihydrate 40 mg/2 mL solution for infusion vial | Is a | False | Irinotecan-containing product in parenteral dose form | Inferred relationship | Some | |
| Irinotecan hydrochloride trihydrate 100 mg/5 mL solution for infusion vial | Is a | False | Irinotecan-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR